Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
J Neurol
    June 2021
  1. MOHAMED AZ, Nestor PJ, Cumming P, Nasrallah FA, et al
    Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    J Neurol. 2021 Jun 30. pii: 10.1007/s00415-021-10669.
    >> Share

    May 2021
  2. LIU X, Dounavi ME, Ritchie K, Wells K, et al
    Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.
    J Neurol. 2021;268:1962-1971.
    >> Share

    April 2021
  3. WEI Y, Liu M, Wang D
    The propagation mechanisms of extracellular tau in Alzheimer's disease.
    J Neurol. 2021 Apr 28. pii: 10.1007/s00415-021-10573.
    >> Share

  4. FIRBANK MJ, O'Brien JT, Durcan R, Allan LM, et al
    Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.
    J Neurol. 2021;268:1284-1294.
    >> Share

    January 2021
  5. ORAD RI, Shiner T
    Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
    J Neurol. 2021 Jan 29. pii: 10.1007/s00415-021-10402.
    >> Share

  6. SEGHEZZO G, Van Hoecke Y, James L, Davoren D, et al
    Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.
    J Neurol. 2021 Jan 26. pii: 10.1007/s00415-021-10403.
    >> Share

    August 2020
  7. SMEDINGA M, Darweesh SKL, Bloem BR, Post B, et al
    Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field.
    J Neurol. 2020 Aug 18. pii: 10.1007/s00415-020-10162.
    >> Share

  8. TORSO M, Ahmed S, Butler C, Zamboni G, et al
    Cortical diffusivity investigation in posterior cortical atrophy and typical Alzheimer's disease.
    J Neurol. 2020 Aug 8. pii: 10.1007/s00415-020-10109.
    >> Share

    July 2020
  9. JISKOOT LC, Poos JM, Vollebergh ME, Franzen S, et al
    Emotion recognition of morphed facial expressions in presymptomatic and symptomatic frontotemporal dementia, and Alzheimer's dementia.
    J Neurol. 2020 Jul 29. pii: 10.1007/s00415-020-10096.
    >> Share

  10. ANDRIUTA D, Perron A, Roussel M, Godefroy O, et al
    Comment on: "Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis".
    J Neurol. 2020 Jul 8. pii: 10.1007/s00415-020-10036.
    >> Share

  11. DAVDA N, Corkill R
    Biomarkers in the diagnosis and prognosis of Alzheimer's disease.
    J Neurol. 2020 Jul 7. pii: 10.1007/s00415-020-10037.
    >> Share

    June 2020
  12. KOLANKO M, Win Z, Patel N, Malik O, et al
    Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis.
    J Neurol. 2020 Jun 18. pii: 10.1007/s00415-020-09969.
    >> Share

  13. VOGLEIN J, Ricard I, Noachtar S, Kukull WA, et al
    Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.
    J Neurol. 2020 Jun 2. pii: 10.1007/s00415-020-09937.
    >> Share

    May 2020
  14. DONAGHY PC, Firbank M, Mitra D, Petrides G, et al
    Microbleeds in dementia with Lewy bodies.
    J Neurol. 2020;267:1491-1498.
    >> Share

    March 2020
  15. IIZUKA T, Kameyama M
    Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    J Neurol. 2020 Mar 13. pii: 10.1007/s00415-020-09790.
    >> Share

    December 2019
  16. WEI G, Irish M, Hodges JR, Piguet O, et al
    Disease-specific profiles of apathy in Alzheimer's disease and behavioural-variant frontotemporal dementia differ across the disease course.
    J Neurol. 2019 Dec 23. pii: 10.1007/s00415-019-09679.
    >> Share

  17. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    >> Share

  18. KLOTH N, Lemke J, Wiendl H, Meuth SG, et al
    Serial position effects rapidly distinguish Alzheimer's from frontotemporal dementia.
    J Neurol. 2019 Dec 5. pii: 10.1007/s00415-019-09662.
    >> Share

    November 2019
  19. WANG X, Mao Z, Ling Z, Yu X, et al
    Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials.
    J Neurol. 2019 Nov 23. pii: 10.1007/s00415-019-09644.
    >> Share

    October 2019
  20. DOORDUIJN AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, et al
    Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
    J Neurol. 2019 Oct 8. pii: 10.1007/s00415-019-09561.
    >> Share

    September 2019
  21. DE SIMONE MS, De Tollis M, Fadda L, Perri R, et al
    Lost or unavailable? Exploring mechanisms that affect retrograde memory in mild cognitive impairment and Alzheimer's disease patients.
    J Neurol. 2019 Sep 30. pii: 10.1007/s00415-019-09559.
    >> Share

  22. LAGARDE J, Olivieri P, Caille F, Gervais P, et al
    [(18)F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.
    J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09530.
    >> Share

    July 2019
  23. ALTOMARE D, Ferrari C, Caroli A, Galluzzi S, et al
    Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09441.
    >> Share

  24. BROWN J, Wiggins J, Lansdall CJ, Dawson K, et al
    Test Your Memory (TYM test): diagnostic evaluation of patients with non-Alzheimer dementias.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09447.
    >> Share

    June 2019
  25. BRUEGGEN K, Dyrba M, Cardenas-Blanco A, Schneider A, et al
    Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    J Neurol. 2019 Jun 21. pii: 10.1007/s00415-019-09429.
    >> Share

  26. PERRI R, Monaco M, Fadda L, Caltagirone C, et al
    Influence of controlled encoding and retrieval facilitation on memory performance of patients with subcortical ischemic vascular dementia and Alzheimer's disease.
    J Neurol. 2019 Jun 18. pii: 10.1007/s00415-019-09411.
    >> Share

  27. BAYART JL, Hanseeuw B, Ivanoiu A, van Pesch V, et al
    Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Abeta42 and T-Tau assays for Alzheimer's disease diagnosis.
    J Neurol. 2019 Jun 10. pii: 10.1007/s00415-019-09418.
    >> Share

    May 2019
  28. TERADA T, Yokokura M, Obi T, Bunai T, et al
    In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    J Neurol. 2019 May 28. pii: 10.1007/s00415-019-09400.
    >> Share

  29. PERRY DC, Datta S, Miller ZA, Rankin KP, et al
    Factors that predict diagnostic stability in neurodegenerative dementia.
    J Neurol. 2019 May 17. pii: 10.1007/s00415-019-09362.
    >> Share

    April 2019
  30. SCHUMACHER J, Cromarty R, Gallagher P, Firbank MJ, et al
    Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis.
    J Neurol. 2019 Apr 21. pii: 10.1007/s00415-019-09323.
    >> Share

  31. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    >> Share

  32. MANCA C, Rivasseau Jonveaux T, Roch V, Marie PY, et al
    Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Abeta42 concentration in the very high range: a prospective study.
    J Neurol. 2019 Apr 8. pii: 10.1007/s00415-019-09315.
    >> Share

  33. SLACHEVSKY A, Forno G, Barraza P, Mioshi E, et al
    Mapping the neuroanatomy of functional decline in Alzheimer's disease from basic to advanced activities of daily living.
    J Neurol. 2019 Apr 4. pii: 10.1007/s00415-019-09260.
    >> Share

    March 2019
  34. MANUEL AL, Foxe D, Bradshaw N, Cordato NJ, et al
    Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia.
    J Neurol. 2019 Mar 5. pii: 10.1007/s00415-019-09261.
    >> Share

    February 2019
  35. MAZZEO S, Padiglioni S, Bagnoli S, Bracco L, et al
    The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study.
    J Neurol. 2019;266:487-497.
    >> Share

    January 2019
  36. JIN B, Liu H
    Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    J Neurol. 2019 Jan 21. pii: 10.1007/s00415-019-09200.
    >> Share

    November 2018
  37. DE SIMONE MS, Perri R, Fadda L, Caltagirone C, et al
    Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9108.
    >> Share

  38. AHMED RM, Goldberg ZL, Kaizik C, Kiernan MC, et al
    Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.
    J Neurol. 2018;265:2562-2572.
    >> Share

    August 2018
  39. ONG SS, Proia AD, Whitson HE, Farsiu S, et al
    Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.
    J Neurol. 2018 Aug 28. pii: 10.1007/s00415-018-9028.
    >> Share

  40. PICKRELL WO, Robertson NP
    New treatments in Alzheimer's disease.
    J Neurol. 2018 Aug 21. pii: 10.1007/s00415-018-9018.
    >> Share

  41. CHANDRA A, Dervenoulas G, Politis M
    Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
    J Neurol. 2018 Aug 17. pii: 10.1007/s00415-018-9016.
    >> Share

  42. BOUGEA A, Stefanis L, Paraskevas GP, Emmanouilidou E, et al
    Neuropsychiatric symptoms and alpha-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    J Neurol. 2018 Aug 6. pii: 10.1007/s00415-018-8992.
    >> Share

  43. WEI H, Zhu X, Li Y
    Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    J Neurol. 2018;265:1844-1849.
    >> Share

    April 2018
  44. ROALF DR, Rupert P, Mechanic-Hamilton D, Brennan L, et al
    Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.
    J Neurol. 2018 Apr 4. pii: 10.1007/s00415-018-8841.
    >> Share

    February 2018
  45. AVGERINOS KI, Kalaitzidis G, Malli A, Kalaitzoglou D, et al
    Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
    J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8768.
    >> Share

    December 2017
  46. EDWARDS M, Robertson NP
    Seizures in Alzheimer's disease: is there more beneath the surface?
    J Neurol. 2017 Dec 4. pii: 10.1007/s00415-017-8694.
    >> Share

    September 2017
  47. DE SIMONE MS, Perri R, Fadda L, De Tollis M, et al
    Different deficit patterns on word lists and short stories predict conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment.
    J Neurol. 2017 Sep 25. doi: 10.1007/s00415-017-8623.
    >> Share

  48. LIGUORI C, Chiaravalloti A, Nuccetelli M, Izzi F, et al
    Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
    J Neurol. 2017 Sep 12. doi: 10.1007/s00415-017-8613.
    >> Share

  49. CECCHINI MA, Yassuda MS, Bahia VS, de Souza LC, et al
    Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.
    J Neurol. 2017 Sep 11. doi: 10.1007/s00415-017-8614.
    >> Share

    August 2017
  50. KARAVASILIS E, Parthimos TP, Papatriantafyllou JD, Papageorgiou SG, et al
    A specific pattern of gray matter atrophy in Alzheimer's disease with depression.
    J Neurol. 2017 Aug 30. doi: 10.1007/s00415-017-8603.
    >> Share

  51. CAI Z, Wan CQ, Liu Z
    Astrocyte and Alzheimer's disease.
    J Neurol. 2017 Aug 18. doi: 10.1007/s00415-017-8593.
    >> Share

  52. HRASTELJ J, Robertson N
    Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.
    >> Share

    January 2017
  53. MALIK GA, Robertson NP
    Treatments in Alzheimer's disease.
    J Neurol. 2017 Jan 24. doi: 10.1007/s00415-017-8395.
    >> Share

    December 2016
  54. TYNKKYNEN J, Hernesniemi JA, Laatikainen T, Havulinna AS, et al
    High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    J Neurol. 2016 Dec 30. doi: 10.1007/s00415-016-8378.
    >> Share

  55. KIMURA A, Takemura M, Saito K, Yoshikura N, et al
    Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    J Neurol. 2016 Dec 20. doi: 10.1007/s00415-016-8362.
    >> Share

    October 2016
  56. CASTRO P, Zaman S, Holland A
    Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    J Neurol. 2016.
    >> Share

  57. BORRELLO L, Cupidi C, Lagana V, Anfossi M, et al
    Angela R.: a familial Alzheimer's disease case in the days of Auguste D.
    J Neurol. 2016.
    >> Share

    May 2016
  58. MASCALCHI M, Bessi V, Ginestroni A, Toschi N, et al
    Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD.
    J Neurol. 2016;263:1024-6.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016